Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Silence Therapeutics Gross Profit (TTM) : 0.0975M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0975M |
| March 31, 2026 | 0.237M |
| December 31, 2025 | -0.0815M |
| September 30, 2025 | -2.124M |
| June 30, 2025 | -4.678M |
| March 31, 2025 | 8.126M |
| September 30, 2024 | 9.074M |
| June 30, 2024 | 12.69M |
| March 31, 2024 | 23.12M |
| Date | Value |
|---|---|
| December 31, 2023 | 18.43M |
| September 30, 2023 | 18.39M |
| June 30, 2023 | 17.91M |
| March 31, 2023 | 11.54M |
| December 31, 2022 | 7.859M |
| September 30, 2022 | 6.962M |
| June 30, 2022 | 5.947M |
| March 31, 2022 | 4.471M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -0.2472M |
| NuCana Plc | -0.3717M |
| Mereo BioPharma Group Plc | -1.195M |
| Compass Pathways Plc | -0.0209M |
| HemoGenyx Pharmaceuticals Plc | -0.7751M |